Calimmune Initiates HIV Stem Cell Study at Two California Research Sites

CalimmuneLogoThe HIV gene medicines company, Calimmune,  announced today that the first patient has begun treatment in a Phase I/II clinical trial designed to determine whether a pioneering genetic medicine approach can help to protect individuals infected with HIV from the effects of the virus. The study, “Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection,” utilizes a gene medicine called Cal-1, developed in the lab of Nobel Laureate Dr. David Baltimore and by Calimmune.Continue reading

2011 AZBio Awards Honorees Announced

The Arizona BioIndustry is Moving Forward Faster in 2011

The Arizona BioIndustry Association has selected finalists and honorees for its annual awards gala to be held at the Sheraton Wild Horse Pass on Oct. 13.  Awards to be presented include: 2011 Michael A. Cusanovich  Educator of the Year, Fast Lane Company Awards, the Arizona Bioscience Company of the Year, the Jon W. McGarity Bioscience Leader of the Year Award, and the Arizona Bioscience Researcher of the Year Award.

Continue reading